Works matching DE "ABATACEPT"

Results: 553
    1
    2
    3
    4
    5
    6
    7

    Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 11, p. e2446336, doi. 10.1001/jamanetworkopen.2024.46336
    By:
    • Sendaydiego, Xavier;
    • Gold, Laura S.;
    • Dubreuil, Maureen;
    • Andrews, James S.;
    • Reid, Pankti;
    • Liew, David F. L.;
    • Goulabchand, Radjiv;
    • Singh, Abha Goyal;
    • Hughes, Grant C.;
    • Pioro, Mathilde;
    • Sparks, Jeffrey A.;
    • Jarvik, Jeffrey G.;
    • Singh, Siddharth;
    • Liew, Jean W.;
    • Singh, Namrata
    Publication type:
    Article
    8

    Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 1, p. e247615, doi. 10.1001/jamanetworkopen.2024.7615
    By:
    • Balevic, Stephen J.;
    • Benjamin Jr, Daniel K.;
    • Powderly, William G.;
    • Smith, P. Brian;
    • Gonzalez, Daniel;
    • McCarthy, Matthew W.;
    • Shaw, Linda K.;
    • Lindsell, Christopher J.;
    • Bozzette, Sam;
    • Williams, Daphne;
    • Linas, Benjamin P.;
    • Blamoun, John;
    • Javeri, Heta;
    • Hornik, Christoph P.
    Publication type:
    Article
    9
    10
    11
    12

    Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 277, doi. 10.3390/jcm9010277
    By:
    • Cassone, Giulia;
    • Manfredi, Andreina;
    • Atzeni, Fabiola;
    • Venerito, Vincenzo;
    • Vacchi, Caterina;
    • Picerno, Valentina;
    • Furini, Federica;
    • Erre, Gian Luca;
    • Tomietto, Paola;
    • Fedele, Anna Laura;
    • Della Casa, Giovanni;
    • Nucera, Valeria;
    • Giannitti, Chiara;
    • Salvarani, Carlo;
    • Sebastiani, Marco
    Publication type:
    Article
    13

    Disease activity and therapeutic drug monitoring of polyglutamates of methotrexate after daily or weekly administration of low‐dose methotrexate in patients recently diagnosed with rheumatoid arthritis.

    Published in:
    Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 6, p. 644, doi. 10.1111/bcpt.13728
    By:
    • Rodríguez‐Báez, Ana Socorro;
    • Huerta‐García, Ana Patricia;
    • Medellín‐Garibay, Susanna Edith;
    • Rodríguez‐Pinal, Cristian Jazmín;
    • Martínez‐Martínez, Marco Ulises;
    • Herrera‐Van Oostdam, David;
    • Abud‐Mendoza, Carlos;
    • Romano‐Moreno, Silvia;
    • Milán‐Segovia, Rosa del Carmen
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis.

    Published in:
    Rheumatology & Therapy, 2023, v. 10, n. 3, p. 707, doi. 10.1007/s40744-022-00519-9
    By:
    • Emery, Paul;
    • Tanaka, Yoshiya;
    • Bykerk, Vivian P.;
    • Huizinga, Thomas W. J.;
    • Citera, Gustavo;
    • Bingham 3rd, Clifton O.;
    • Banerjee, Subhashis;
    • Soule, Benjamin P.;
    • Nys, Marleen;
    • Connolly, Sean E.;
    • Lozenski, Karissa L.;
    • Zhuo, Joe;
    • Wong, Robert;
    • Huang, Kuan-Hsiang Gary;
    • Fleischmann, Roy
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32

    A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.

    Published in:
    Rheumatology & Therapy, 2021, v. 8, n. 3, p. 1159, doi. 10.1007/s40744-021-00330-y
    By:
    • Cohen, Stanley;
    • Wells, Alvin F.;
    • Curtis, Jeffrey R.;
    • Dhar, Rajat;
    • Mellors, Theodore;
    • Zhang, Lixia;
    • Withers, Johanna B.;
    • Jones, Alex;
    • Ghiassian, Susan D.;
    • Wang, Mengran;
    • Connolly-Strong, Erin;
    • Rapisardo, Sarah;
    • Gatalica, Zoran;
    • Pappas, Dimitrios A.;
    • Kremer, Joel M.;
    • Saleh, Alif;
    • Akmaev, Viatcheslav R.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40

    Efficacy and Safety in the Continued Treatment With a Biosimilar Drug in Patients Receiving Infliximab: A Systematic Review in the Context of Decision-Making From a Latin-American Country.

    Published in:
    Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01010
    By:
    • Mezones-Holguin, Edward;
    • Gamboa-Cardenas, Rocio Violeta;
    • Sanchez-Felix, Gadwyn;
    • Chávez-Corrales, José;
    • Helguero-Santin, Luis Miguel;
    • Laban Seminario, Luis Max;
    • Burela-Prado, Paula Alejandra;
    • Castro-Reyes, Maribel Marilu;
    • Fiestas, Fabian
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    A Rare Central Nervous System Involvement Due to CTLA-4 Gene Defect.

    Published in:
    Archives of Neuropsychiatry / Nöropsikiyatri Arşivi, 2022, v. 59, n. 3, p. 248, doi. 10.29399/npa.27900
    By:
    • ROVSHANOV, Sahib;
    • GÖÇMEN, Rahşan;
    • BARIŞTA, İbrahim;
    • ÇAĞDAŞ, Deniz;
    • ÜNER, Ayşegül;
    • ÇİLİNGİR, Vedat;
    • TEZER FİLİK, İrsel;
    • TAN, Çağman;
    • AYTEKİN, Elif SOYAK;
    • TEZCAN, İlhan;
    • ÖZEN, Pınar ACAR;
    • TUNCER, Aslı
    Publication type:
    Article